Related Experiment Videos
Distinctive structure and function of human apolipoprotein variant ApoA-IV-2
R B Weinberg1, M K Jordan, A Steinmetz
1Department of Medicine, University of Texas Health Science Center, Houston 77225.
The Journal of Biological Chemistry
|October 25, 1990
Summary
ApoA-IV-2, a variant of apolipoprotein A-IV, exhibits enhanced alpha-helical structure and phospholipid binding. This structural difference increases its efficiency in activating lecithin-cholesterol acyltransferase, potentially explaining higher high-density lipoprotein levels in carriers.
Area of Science:
- Biochemistry
- Molecular Biology
- Lipid Metabolism
Background:
- Apolipoprotein A-IV (apoA-IV) plays a crucial role in lipoprotein metabolism and high-density lipoprotein (HDL) function.
- Genetic variations, such as the apoA-IV-2 isoform, can influence protein structure and function.
- Understanding these variations is key to elucidating their impact on lipid profiles and cardiovascular health.
Purpose of the Study:
- To investigate the molecular structure, phospholipid binding, and enzymatic activity of the apoA-IV-2 isoform.
- To compare the biophysical properties of apoA-IV-2 with the common apoA-IV-1 isoform.
- To determine the functional consequences of apoA-IV-2's structural characteristics on lecithin-cholesterol acyltransferase (LCAT) activation.
Main Methods:
- Circular dichroism spectroscopy to assess alpha-helical content.
- Fluorescence titration and quenching to study phospholipid binding affinity and accessibility of tryptophan residues.
- Enzyme kinetic studies to measure LCAT activation efficiency with various phospholipid substrates.
Main Results:
- ApoA-IV-2 demonstrated a significantly higher alpha-helical content (75%) compared to apoA-IV-1 (56%), increasing to 88% upon phospholipid binding.
- ApoA-IV-2 exhibited a 2.4-fold greater affinity for phospholipid vesicles (Ka = 3.3 x 10^6 L/mol) than apoA-IV-1.
- ApoA-IV-2 showed 36-71% greater efficiency in activating LCAT compared to apoA-IV-1, possibly due to deeper penetration into phospholipid surfaces.
Conclusions:
- ApoA-IV-2 possesses distinct structural features, including increased alpha-helicity, stability, and hydrophobicity, compared to apoA-IV-1.
- These structural attributes confer enhanced phospholipid binding and a greater capacity to activate LCAT.
- The improved LCAT activation by apoA-IV-2 may contribute to the elevated HDL levels observed in individuals carrying this apoA-IV variant.